Unblinded: A Clinical Trial Podcast

How Open Source and AI are Rewriting the Rules of Clinical Data

In this episode, Novo Nordisk’s Rhona O'Donnell and Ibrahim Kamstrup-Akkaoui explore how the combination of open source tools and AI is reshaping the future of clinical d

Deep Pockets, Short Arms: Is MedTech Ready for AI?

In this episode of Unblinded, host Manny Vazquez is joined by Leianne Ebert, Head of Data Operations at Alcon, and co-host John Acampado, Senior Director of Clinical Stra

The Economics of Clinical Trial Outsourcing

Joel White, owner of Marketcap Consulting, together with Veeva’s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by t

A People-Focused Approach to a Risk-Based Future in Clinical Trials

In this episode, host Manny Vazquez is joined by Noeleen Turner, head of clinical data management at UCB, and Anna Hayes, senior director of clinical data management at V

ICH E6(R3): Shifting the Paradigm from Process to Purpose

In this episode, we pull back the curtain on the monumental effort required to reshape global clinical trial standards. Manny and guests Lisbeth Bregnhoj and Cheryl Grand

The Unstuck Industry: A New Equitable Model for Pharma

Brian Johnson, former head of R&D technology at Takeda, now consultant, shares his unique perspective on a topic that’s top-of-mind for many: how do you introduce new tec

Innovation from the Inside: How Sites Are Redefining Clinical Research

Manny is joined by co-host Denali Rose and MSKCC’s Joe Lengfellner, to discuss the shifting focus from a one-size-fits-all approach to redefine site centricity. They talk

Patient vs. Process: Bridging the Gap for a Better Trial Experience

Join host Manny Vazquez as he sits down with Joyce Moore, leading voice in patient recruitment with over 25 years of experience in the industry, most recently at Allucent

Biggest Risks (and Possible Rewards) of AI in Clinical Data

Are we any closer to working out the human-machine relationship needed to embed AI in clinical development? To discuss this and all things automation, Veeva’s Chief Tech

The State of Patient Engagement: From a Patient Advocate

Manny Vazquez (our new host) interviews Trishna Bharadia, a patient engagement consultant and advocate. Since receiving a life-changing diagnosis 15 years ago, Trishna ha

Is a Heavy Tech Burden the Price of Progress for Sites?

Richard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by

AI and Clinical Transformation: High-Value or Hype?

Novo Nordisk’s Vice President for Clinical Data Operations and Insights Ibrahim Kamstrup-Akkaoui joins Richard this week for episode 4 of Season 3. As Ibrahim explains, t

Does Data Science Require Data Perfection?

Pfizer’s Vice President for Data Monitoring and Management Demetris Zambas joins Richard in the hot seat and shares his fascinating journey through life sciences: from ho

The Launch of Boehringer Ingelheim’s One Medicine Program

Nicole Raleigh hosts this special episode on-site from Boehringer Ingelheim’s Human Pharmacology Center in Biberach, Germany. Andrea Kloeble and Daniel Schwenk are part o

Against All Odds: Finding a Treatment for SPG50

We can think of no better way to kick off Season 3. In a deeply personal and moving episode, two patient advocates share their stories of working tirelessly to deliver a

Are We Too Risk Averse in Clinical Research?

This week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. Already well-known in our indu

Putting Patient Data at the Heart of Your Strategy

In this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect novel insi

Does Patient Choice Equal Site Headaches?

The first episode of Season 2 is now out! This week, Richard Young speaks to Helen Shaw, co-founder and director of clinical operations at VCTC (a virtual site) and Marie

Sites Are Voicing Their Concerns, But Are We Listening?

In this week’s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&R (an independent research site in the Netherlands), and Bree Bu

Transforming Clinical Operations: What Comes Next?

In this episode, Richard Young speaks with Bayer’s Head of Clinical Trial Management Services and Solutions, Emma Earl. With over 20 years of experience, Emma is perfectl